The preparation and characterization of tris-pyridyl bispidine (3,7-diazabicyclo[3.3.1]nonane) derivatives with benzimidazole and imidazole donor groups at the N-3 position of the bispidine skeleton and their copper(II) complexes are reported. The impact of the hetaryl substituents on the configurational isomerism of piperidones and their corresponding bispidones has been studied by NMR spectroscopy, revealing the exclusive appearance in the enol form for the piperidones in solution and the trans-configuration regarding the two pyridyl substituents, as well as the sole formation of the unsymmetric exo-endo isomers for the corresponding bispidones. Thus, the bispidones are preorganized ligands for building pentacoordinated complexes, confirmed by the preparation and characterization of the corresponding Cu(II) complexes. Of the di-pyridyl piperidones with benzimidazole and imidazole substituents, and of the Cu(II) complex of the benzimidazole-containing bispidone, crystals have become available for the analysis by X-ray diffraction, showing that the piperidones form the enol tautomers also in the solid state.
Introduction
The advantageous properties of numerous 3,7-diazabicyclo[3.3.1]nonane (bispidine) derivatives have attracted much attention and caused intensive research efforts in different directions. The variable number, type and position of the donor groups provide a variety of tailor-made coordination sites for metal ions with different preferences with regard to size, shape and electronic properties [1] . Bispidine ligands form very stable complexes especially with copper(II) ions [2 -4] . The thermodynamic stability of copper(II)-bispidines is in the same range as that of copper(II) complexes with azamacrocyclic ligands. Furthermore, the bispidine skeleton opens suitable pathways to introduce biomolecules, which are important in view of the pharmaceutical targeting of such complexes. Due to these interesting features, bispidines are predestined as attractive bifunctional chelating agents for the development of target-specific copper-based radiopharmaceuticals [5 -7] . Thus, we have shown that hexadentate ligands with pyridine 0932-0776 / 11 / 0700-0721 $ 06.00 c 2011 Verlag der Zeitschrift für Naturforschung, Tübingen · http://znaturforsch.com units in the positions C-2, C-4, N-3, and N-7 form stable 64 Cu(II) complexes under mild conditions [6] . This tetrakis-pyridyl bispidine ligand adopts a doublechair conformation with endo-endo orientation of the pyridyl groups in the C-2/C-4 positions to give sixcoordinate complexes with an efficiently encapsulated and shielded copper(II) ion. Interestingly, hexadentate bispidine ligands are quite scarce, and only bispidinebased bis(amine)tetrakis(pyridine) derivatives have been described [2, 4, 6 -8] .
Like many biologically relevant copper complexes, especially imidazole-containing derivatives appear to be promising due to their favorable complex formation and solubility characteristics [9 -11] . Hitherto, only the synthesis and complexation properties of a tetradentate bispidine derivative with methylimidazole groups in C-2/C-4 positions have been reported [12, 13] . The Cu(II) complex of this tetradentate ligand shows square pyramidal coordination geometry completed by an additional chloro ligand. It is worth mentioning that the imidazolyl nitrogen donors form quite short bonds with the Cu(II) center Fig. 1 (color online) . ORTEP representation of 1 (left) and 2 (right) shown with 30 % probability displacement ellipsoids and the atom labeling adopted.
(1.967, 1.971Å) pointing to strong interactions. Owing to these interesting features of complexation, we have set out to develop new bispidine derivatives with imidazole-containing donor groups.
We report here the synthesis of bispidone ligands with imidazole and benzimidazole substituents in N-3 position, the X-ray structure analyses of the corresponding piperidone intermediates and of the Cu(II) complex of the benzimidazolyl bispidone ligand. In parallel, the impact of the imidazol substituents on the configurational isomerism of piperidones and their corresponding bispidones is discussed based on 1 H NMR spectroscopy studies.
Results and Discussion
The bispidine skeleton is assembled in two consecutive Mannich reactions, starting with piperidone formation by condensation of dimethyl 3-oxopentanedioate, pyridine-2-carbaldehyde, and (1H-benzimidazol-2-yl)-or (1H-imidazol-2-yl)methanamine. The purified piperidones 1 and 2 have been characterized in solution by NMR analysis. It was found that both compounds show only NMR signals of the unsymmetric enol form in CDCl 3 solution: For instance the 1 H NMR spectrum of 1 shows two separate singlets at δ = 3.56 and 3.76 ppm of methyl ester CH 3 groups and three separate signals of CH groups (C-1, C-2, C-4, the numbering in Scheme 2 and Fig. 1 is adopted from the bispidone numbering of Scheme 1 for better comparScheme 1 (color online). The hexadentate bispidone ligand with skeleton numbering. Scheme 2. Observed trans isomers of 1 and 2 in their enol form (the numbering in Scheme 2 and Fig. 1 Table 1 . Crystal structure data for 1, 2 and 3Cu.
2 )/3 and A and B are constants adjusted by the program;
, where n obs is the number of data and n param the number of refined parameters. Table 2 . Selected bond lengths (Å) for piperidones 1 and 2 with estimated standard deviations in parentheses.
1.346(17) 1.340(3) Table 3 . Selected bond lengths (Å) and angles (deg) for 3Cu with estimated standard deviations in parentheses.
77. 6(6) signal at 96.0 ppm for the sp 2 -hybridized carbon atom C-9 gives evidence for the enol form. The detection of only one set of NMR signals for each compound points to the existence of only one diastereomeric form regarding the configuration at C-2 and C-4 in solution (Scheme 2). Additional diastereomers would appear as different sets of signals side by side. An X-ray crystal structure determination identified the present isomeric form as the trans isomer regarding the C-2/C-4 orientation. The molecular structures are displayed in Fig. 1 , and crystallographic data are given in Tables 1 -3 . Piperidone 1 crystallizes in the triclinic space group P1 with two molecules in the unit cell. Due to the centrosymmetry of the space group, the compound crystallizes as a racemate. The two pyridine rings are in trans-position. Between the six-membered benzene ring (C26···C31) of the benzimidazole substituent and a benzene ring of the second molecule in the unit cell a π-π interaction is observed with a distance of d = 3.864Å between the ring centroids and a dihedral angle of α = 0 • between the planes (Fig. 2) .
Piperidone 2 crystallizes in the monoclinic space group P2 1 /n with four molecules in the unit cell. The molecule contains three asymmetric carbon atoms (C-2, C-1 and C-9). Due to the centrosymmetry of the crystals, the compound is racemic with two enantiomers of the molecule. The pyridine rings are in trans-position. There are no solvent molecules and no voids in the structure. In the crystal structures of both piperidones 1 and 2 an intramolecular hydrogen bond (d(O1···O4) = 2.544(19) (1); 2.550(4)Å (2)) between the carbonyl oxygen atoms of the methyl ester and the hydroxyl group clearly indicates the existence of the piperidones in the enol form in the solid state. The short bond lengths (C5-C9) of 1.355(19)Å in 1 and 1.348(4)Å in 2 are also characteristic for C-C double bonds in enols. In the second step of the bispidone synthesis, the isolated piperidones 1 and 2 were reacted with formaldehyde and 2-pyridyl-methylamine to form the bicyclic bispidones 3 and 4 (Scheme 3). According to NMR spectra showing one single set of signals for each compound, the bispidones 3 and 4 were isolated exclusively as the unsymmetric exo-endo isomers. Evidence for this conclusion is given in the 1 H NMR spectrum by two different singlets for methyl ester CH 3 groups at δ = 3.37 and 3.75 ppm, by three characteristic pyridyl CH-N signals with the largest downfield shifts (δ = 8.18, 8.61 and 8.74 ppm) and by two singlets (δ = 4.55 and 5.53 ppm) for the two CH units at C-2 and C-4 position. The assignment as exo-endo isomers was finally confirmed by X-ray crystal structure analysis of the copper complex 3Cu. Experiments to convert the isolated exo-endo into the endo-endo isomers by solvolysis in refluxing ethanol according to references [1, 6, 9] Scheme 3. Bispidones 3 and 4 are isolated exclusively as exo-endo isomers.
failed due to decomposition because of the low thermal stability of these two bispidones.
The formation of the copper(II) complexes 3Cu and 4Cu can be observed immediately by the appearance of blue to turquoise color after addition of copper salts to 3 or 4 in methanolic solution. Detailed information on the coordination behavior and related structural aspects are available from singlecrystal X-ray data of 3Cu (Fig. 3) . In the case of the (benz)imidazol-substituted bispidone-type ligand, the isomerism assigned at positions C-2 and C-4 is reflected in the fivefold coordination of the copper ion by the ligand.
In 3Cu the bispidone ligand 3 acts only as a pentadentate chelator since one of the dangling pyridine groups is not capable to coordinate the copper ion because of the unfavorable configuration at the carbon atom C4. Complex 3Cu crystallizes in the 
Conclusion
New functionalized piperidones containing benzimidazolyl (1) or imidazolyl (2) in addition to two pyridyl substituents have been synthesized and characterized by NMR and X-ray diffraction studies. Interesting similarities regarding their unsymmetric trans isomers and the enol forms both in solution and in crystalline state were observed. After conversion to their corresponding bispidones 3 and 4 accompanied by introduction of a third pyridyl substituent, the exclusive formation of analogous unsymmetric exo-endo isomers has been observed, which means that both ligands are preorganized to build pentacoordinated complexes. The bispidone Cu(II) complexes 3Cu and 4Cu have been prepared and characterized. The expected fivefold coordination of copper(II) by the ligand was confirmed by X-ray diffraction analysis for 3Cu. Further experiments to introduce imidazole groups into the positions C-2 and C-4 of bispidones, and to study their impact on the configuration of this type of ligands which then might be able to act in a hexadentate fashion to coordinate the copper(II) ion are underway.
Experimental Section

General
Chemical reagents and solvents were purchased from commercial sources and used without further purification. Melting points were determined on a Mikroheiztisch Boetius apparatus by VEB Carl Zeiss Jena. 1 H and 13 C NMR spectra were recorded on a 400 MHz Varian Inova spectrometer. The chemical shifts (δ , ppm) are relative to TMS or the solvent. Elemental analyses were performed on a Leco Elemental Analyzer CHNS-932. Electrospray ionization mass spectrometry (ESI-MS) was carried out using a micromass tandem quadrupole mass spectrometer (Quattro LC). Thin layer chromatography (TLC) was performed using RP-18-F 254 TLC plates (Merck), developed in a 10 : 8 : 5 mixture chloroform/methanol/ammonia. HPLC was performed using either of two eluents (eluent A: acetonitrile, containing 0.1 % trifluoroacetic acid; eluent B: water, containing 0.1 % trifluoroacetic acid). The purity of the compounds was determined on a Knauer Smartline system, including a pump 1000, a UV detector 2500, and a manager 5000; Jupiter 4 µm C12 90Å (Phenomenex), 250 × 4.6 mm 2 , elution gradient 10 % to 70 % A in 20 min, 1 mL min −1 .
Dimethyl 1-((1H-benzimidazol-2-yl)methyl)-4-hydroxy-2,6-di(pyridin-2-yl)-1,2,3,6-tetrahydropyridine-3,5-dicarboxylate (1)
(1H-Benzimidazol-2-yl)methanaminium chloride (2.00 g) was converted into the free base with 50 mL of ammonia (25 % aq.), and subsequently extracted into 50 mL of chloroform. The solvent was removed. To a stirred solution of 334 mg (2.68 mmol) (1H-benzimidazol-2-yl)methanamine in 2 mL methanol, 394 µL (2.68 mmol) dimethyl 3-oxopentanedioate and 511 µL (5.35 mmol) pyridine-2-carbaldehyde dissolved in 47 µL water were added. The reaction mixture was stirred for 4 h at r. t. until a bright-brown solution occurred. The solvent was removed under reduced pressure. The residue was dissolved in dichloromethane, and the solvent was removed again. This procedure was repeated twice resulting in a yellow powder. The product was stirred for 12 h in diethyl ether. 149.7, 154.4, 157.1, 161.1, 170.1, 171.3, 172 .0. -ESI-MS: m/z (%) = 500.19 (100) [M+H] + . -HPLC: t R = 13.78 min.
Dimethyl 1-((1H-imidazol-2-yl)methyl)-4-hydroxy-2,6-di-(pyridin-2-yl)-1,2,3,6-tetrahydropyridine-3,5-dicarboxylate (2)
With stirring, a solution of 329 µL (2.24 mmol) dimethyl 3-oxopentanedioate dissolved in 2 mL methanol was added to 428 µL (4.48 mmol) pyridine-2-carbaldehyd, 381 mg (2.24 mmol) (1H-imidazol-2-yl)methanaminium chloride [14] , 47 µL water and 776 µL (5.6 mmol) triethylamine. The reaction mixture was stirred for 4 h until a milky solution had formed. Triethylammonium chloride was separated by filtration. The solvent was removed under reduced pressure. The residue was dissolved in 25 mL water and extracted thrice with 25 mL chloroform. The organic phase was dried over Na 2 SO 4 , and the solvent was removed in vacuo. The product was stirred for 12 h in diethyl ether. 
Dimethyl 3-((1H-benzimidazol-2-yl)methyl)-9-oxo-2,4-di(pyridin-2-yl)-7-(pyridin-2-ylmethyl)-3,7-diazabicyclo-[3.3.1]nonane-1,5-dicarboxylate (3)
To 100 mg (0.2 mmol) of 1 dissolved in 2 mL tetrahydrofuran, 25 µL (0.24 mmol) 2-picolylamine and 36 µL (0.48 mmol) formaldehyde (37 % aq.) were added. The reaction mixture was refluxed for 7 h to give a clear brown solution. After removing the solvent, the solid residue was dissolved in 10 mL of an acetonitrile/water mixture (1/4) to allow the separation of insoluble by-products. The solvent was removed in vacuo. The crude product was recrystallized from acetone to give 3 as a colorless solid. 
X-Ray structure analyses
The single-crystal X-ray data collection was carried out on a Bruker AXS SMART diffractometer at r. t. (3Cu at 190 K) using MoK α radiation (λ = 0.71073Å), monochromatized by means of a graphite crystal. All data were collected at r. t. Data reductions and absorption corrections were performed with the Bruker AXS SAINT [15] and SAD-ABS [16] packages, respectively. The structures were solved by Direct Methods and refined by full-matrix least-squares calculations using the programs SHELXS/L [17] . Anisotropic displacement parameters were employed for non-hydrogen atoms. The hydrogen atoms were treated isotropically with U iso = 1.2 times the U eq value of the parent atom. In case of methylene groups U iso = 1.5 times the U eq value was chosen. Crystal data and refinement details are summarized in Table 1 .
CCDC 809601 (1), 809602 (2) and 809603 (Cu3) contain the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.cdc.cam.ac.uk /data request/cif.
